Ehave a provider of digital therapeutics (EHVVF) signed a licensing partnership with MyLifeID after a 1:1 meeting at the TSI Travel Tech Investment Symposium on Jan 8th in Miami, FL. Ben Kaplan, CEO of Ehave attended the TSI Investment Symposium as an angel investor. Jeff Cohen, CEO of MyLifeID had a 1:1 meeting with Kaplan which led to the licensing of MyLifeID’s product.
“We believe it’s important that people have their medical records available at all times, especially when traveling,” said Jeffrey W. Cohen, Chief Executive Officer of MyLifeID, Inc. “By partnering with Ehave, MyLifeID helps ensure doctors have access to critical data for a more comprehensive understanding of the patient. This leads to a more accurate diagnosis and treatment.”
MyLifeID is the creator of the Pocket Cloud 2.0, a 32GB credit card-sized USB storage drive designed to hold a person’s critical data. Including, general health and medical history, as well as their mental health information, X-rays, emergency contact lists, prescription drug information, and immunization history. Visit https://www.MyLifeID.com for more information or call 702-832-0112.
Ehave, Inc. (EHVVF) is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Ehave’s primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes.